NCT02981108 2023-01-23
A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1/2 Unknown
Clinical Trials
5 trialsNCT03849768 2023-01-20
A Study to Evaluate Safety and Efficacy of HS-10296 as First-Line Treatment in Patients
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT00874614 2020-02-20
A Study Evaluating Ultratrace Iobenguane I131 in Patients With Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma
Molecular Insight Pharmaceuticals, Inc.
Phase 2 Unknown
NCT01520558 2017-06-29
CNDO-109-AANK for AML in First Complete Remission (CR1)
Coronado Biosciences, Inc.
Phase 1/2 Unknown
NCT00262067 2013-12-13
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
Genentech, Inc.
Phase 3 Unknown